DAX24.456 +0,1%Est505.660 +0,3%MSCI World4.336 +0,2%Top 10 Crypto16,63 +1,0%Nas22.844 +0,4%Bitcoin102.625 -0,2%Euro1,1738 +0,2%Öl64,41 +0,1%Gold3.868 +0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
DroneShield A2DMAA Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Tesla A1CX3T Siemens Energy ENER6Y HENSOLDT HAG000 Novo Nordisk A3EU6F Alibaba A117ME Plug Power A1JA81 BASF BASF11 thyssenkrupp 750000 Lufthansa 823212 Deutsche Telekom 555750 Bayer BAY001
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX knapp im Plus - Rekord in Sicht -- BMW steigert US-Absatz deutlich -- Investoren wollen Billionen-Vergütung für Tesla-CEO Musk stoppen -- IONOS, Boeing, Roche im Fokus
Top News
Rohstoffe im September 2025: So performten Goldpreis, Ölpreis und Co. Rohstoffe im September 2025: So performten Goldpreis, Ölpreis und Co.
Bitcoin, Dogecoin, Ethereum & Co. am Mittag Bitcoin, Dogecoin, Ethereum & Co. am Mittag
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Günstig global investieren mit unserem neuen FINANZEN.NET MSCI WORLD ETF - nur 0,12 % TER. Jetzt informieren!

Insmed Aktie

Kaufen
Verkaufen
Insmed Aktien-Sparplan
129,00 EUR +5,00 EUR +4,03 %
FSE
152,81 USD +5,53 USD +3,75 %
BTT
Insmed jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.26,56 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JJA3

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4576693075

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolINSM

Insmed Aktien News

DatumMeistgelesen
PR NewswireInsmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
PR NewswireInsmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Reports First Quarter 2023 Financial Results and Provides Business Update
PR NewswireInsmed to Host Investor and Analyst Event on May 8, 2023
PR NewswireInsmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
PR NewswireInsmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at Two March Conferences
PR NewswireInsmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
PR NewswireInsmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023
PR NewswireInsmed To Present at the SVB Securities Global Biopharma Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed To Present at the 41st Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Nasdaq 47th Investor Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at Three November Conferences
PR NewswireInsmed Ranks No. 1 on Science's 2022 Top Biopharma Employers List
PR NewswireInsmed Reports Third Quarter 2022 Financial Results and Provides Business Update
PR NewswireInsmed Announces Strategic Financings Totaling $775 Million
PR NewswireInsmed to Host Third Quarter 2022 Financial Results Conference Call on Thursday, October 27, 2022
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Holds Inaugural Global Day of Good - A Company-Wide Day of Service

Insmed News

Insmed News: auf dieser Seite finden Sie alle Insmed News und Nachrichten zur Insmed Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Insmed News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Insmed News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.